A 12-week pilot study found that time-restricted eating was feasible and well tolerated in 20 people with early-stage Huntington's disease. It was also associated with favorable changes in clinical measures and plasma neurofilament light levels.
Source: Human trial, no comparison group, 20 individuals with early-stage Huntington's disease. Everyone in it got the treatment, so there is no group to compare with. Changes could come from other causes; this is early evidence.
What was found
A 12-week pilot study found that time-restricted eating (TRE) was feasible and well tolerated in people with early-stage Huntington's disease.
The study reported that TRE was associated with favorable changes in clinical measures of Huntington's disease and in plasma neurofilament light levels.
How it was done
This was a 12-week open-label pilot trial with 20 individuals who had early-stage Huntington's disease.
Participants followed an 8-hour time-restricted eating schedule alongside standard-of-care diet and activity recommendations.
What it does not show
This was a small pilot study with 20 participants and did not include a comparison group.
The study was open-label, meaning participants knew they were receiving the intervention.
What happens next
The results support the need for further investigation of time-restricted eating as a potential lifestyle intervention in Huntington's disease.
Who was talking about it
- Dr. Rhonda Patrick on X (2026-09-22): Dr. Rhonda Patrick said that a time-restricted eating finding is especially interesting for Huntington's disease, which has no approved treatment to slow its progression. See the post
The source
This is news, reported from the source above. It is not medical advice and not a recommendation. Talk to your doctor or pharmacist before you change any medicine or supplement.